Gabriel Motoa Cardona, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 2 | 2021 | 915 | 0.790 |
Why?
|
| HTLV-I Infections | 1 | 2021 | 103 | 0.720 |
Why?
|
| Cryptococcosis | 1 | 2021 | 104 | 0.700 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2021 | 164 | 0.690 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2021 | 353 | 0.610 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 364 | 0.600 |
Why?
|
| Cataract Extraction | 1 | 2021 | 465 | 0.560 |
Why?
|
| Candida | 1 | 2016 | 173 | 0.510 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 787 | 0.510 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 1005 | 0.480 |
Why?
|
| Candidiasis | 1 | 2016 | 363 | 0.460 |
Why?
|
| Organ Transplantation | 1 | 2022 | 1150 | 0.410 |
Why?
|
| Preoperative Care | 1 | 2021 | 2249 | 0.410 |
Why?
|
| Influenza, Human | 1 | 2022 | 1516 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 4 | 2021 | 7403 | 0.320 |
Why?
|
| Liver Transplantation | 1 | 2020 | 2325 | 0.310 |
Why?
|
| Colombia | 5 | 2019 | 276 | 0.260 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2022 | 167 | 0.200 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2021 | 142 | 0.180 |
Why?
|
| Deep Sedation | 1 | 2021 | 118 | 0.170 |
Why?
|
| Lithiasis | 1 | 2019 | 19 | 0.170 |
Why?
|
| Intensive Care Units | 3 | 2019 | 3732 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15637 | 0.160 |
Why?
|
| Ascites | 1 | 2021 | 338 | 0.160 |
Why?
|
| Haiti | 1 | 2021 | 549 | 0.160 |
Why?
|
| Bronchial Diseases | 1 | 2019 | 150 | 0.160 |
Why?
|
| beta-Lactams | 1 | 2020 | 157 | 0.160 |
Why?
|
| Penicillins | 1 | 2021 | 406 | 0.160 |
Why?
|
| Anti-Allergic Agents | 1 | 2019 | 149 | 0.150 |
Why?
|
| Pleural Effusion | 1 | 2021 | 342 | 0.150 |
Why?
|
| Chagas Disease | 1 | 2019 | 167 | 0.150 |
Why?
|
| Conscious Sedation | 1 | 2021 | 529 | 0.140 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2019 | 192 | 0.140 |
Why?
|
| Seasons | 1 | 2022 | 1519 | 0.140 |
Why?
|
| beta-Lactamases | 2 | 2016 | 304 | 0.140 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2016 | 6 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1829 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2021 | 749 | 0.130 |
Why?
|
| Bacteremia | 1 | 2021 | 980 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 565 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 539 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2022 | 80168 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2021 | 1406 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2014 | 272 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 1348 | 0.100 |
Why?
|
| Anaphylaxis | 1 | 2019 | 755 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2014 | 237 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2021 | 1973 | 0.100 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 523 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1279 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2014 | 586 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 812 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2021 | 3220 | 0.070 |
Why?
|
| Cross Infection | 1 | 2016 | 1432 | 0.070 |
Why?
|
| Humans | 14 | 2022 | 758406 | 0.060 |
Why?
|
| Methicillin | 1 | 2021 | 62 | 0.050 |
Why?
|
| Cefazolin | 1 | 2021 | 94 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 219935 | 0.050 |
Why?
|
| Asthma | 1 | 2019 | 6172 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 168218 | 0.040 |
Why?
|
| Pseudomonas | 1 | 2019 | 123 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 41256 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 39872 | 0.040 |
Why?
|
| Trypanosoma cruzi | 1 | 2019 | 206 | 0.040 |
Why?
|
| Female | 6 | 2021 | 390323 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58683 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 17275 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 87892 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 100 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2021 | 1268 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 58808 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 1460 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 2850 | 0.030 |
Why?
|
| Carbapenems | 1 | 2014 | 123 | 0.030 |
Why?
|
| Acinetobacter baumannii | 1 | 2014 | 115 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2014 | 254 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 460 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 219568 | 0.020 |
Why?
|
| Male | 4 | 2022 | 358747 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 3175 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6493 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6068 | 0.020 |
Why?
|
| Public Health | 1 | 2019 | 2658 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 1275 | 0.020 |
Why?
|
| Critical Illness | 1 | 2019 | 2703 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6439 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12440 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12951 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2014 | 2606 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10652 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 64378 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2014 | 4215 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 3824 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 73809 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15651 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22029 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 29742 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25956 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72136 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 54137 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 26183 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 36055 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42062 | 0.010 |
Why?
|
| Child | 1 | 2014 | 79818 | 0.000 |
Why?
|